Home >> NIPERs


National Institute of Pharmaceutical Education & Research

Indian Pharma Industry has been a global leader in Generic drugs. In order to acquire leadership position in drug discovery and development and to continue to excel in the formulations, Government recognized that human resources/talent pool is very critical. Thus Government of India has set up National Institute of Pharmaceutical Education & Research (NIPER) at SAS Nagar Mohali as a registered society under the Society Registered Act 1860, Subsequently the Institute was given statutory recognition by an act of Parliament, NIPER Act, 1998 and the Institute declared as an Institute of National Importance.

During 2007-08, six new NIPERs were started at Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli with the help of Mentor Institute as under:

NIPER Mentor Institute Academic Session Started
NIPER, Mohali - 1998
NIPER, Ahmedabad B V Patel PERD Center, Ahmedabad 2007
NIPER, Guwahati Guwahati Medical College, Guwahati 2008
NIPER, Hajipur Rajendra Memorial Research Institute of Medical Science (RMRIMS-Patna) under ICMR 2007
NIPER, Hyderabad CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 2007
NIPER, Kolkata CSIR-Indian Institute of Chemical Biology, Kolkata 2007
NIPER, Raebareli CDIR-Central Drug Research Institute, Lukhnow 2008

With appointment of regular Directors in all NIPERs, presently all these institutes are functioning independently.

The main objectives of NIPER are as under:-

  • Nurture and promote quality and excellence in pharmaceutical education and research:
  • Run Master's, Doctoral and post-Doctoral courses and research in pharmaceutical education
  • Develop a multi-disciplinary approach in carrying out research and training of pharmaceutical manpower ; and
  • Act as nucleus for interaction between academic and industry by undertaking sponsored and funded research as well as consultancy projects

Admission Procedure in NIPERs:

At present these NIPERs impart Ph.D and PG level education and grant degree under the NIPER Act, 1998. The students are selected through a common entrance examination. Each Master student is given a fellowship of Rs. 12,400/- per month and Ph.D scholars @ Rs. 31,000-35,000/-.

National Institutional Ranking Framework (NIRF):

NIPERs 2017 2018 2019 2020 2021
Mohali 2nd 1st 3rd 3rd 4th
Hyderabad 5th 6th 6th 5th 6th
Ahmedabad - 14th 9th 8th 10th
Guwahati - - - 11th 19th
Raebareli - - - 18th 13th
Kolkata - - - 27th 33rd


NIPER, SAS Nagar, Mohali was initially registered as a society under the Societies Act. The faculty for the institute was appointed in 1994. In 1998, Parliament enacted National Institute of Pharmaceutical Education and Research Act, 1998. NIPER was declared as an "Institute of National Importance" under the Act of Parliament on 26th June 1998. NIPER is a member of Association of Indian Universities.


  1. Medicinal Chemistry
  2. Pharmacoinformatics
  3. Natural Products
  4. Traditional Medicine
  5. Pharmaceutical Analysis
  6. Pharmacology & Toxicology
  7. Regulatory Toxicology
  8. Pharmaceutical Technology (Formulations)
  9. Pharmaceutical Technology (Process Chemistry)
  10. Pharmaceutical Technology (Biotechnology)
  11. Pharmaceutics
  12. Biotechnology
  13. Pharmacy Practice
  14. Clinical Research
  15. Pharmacy Practice
  16. Medical Devices
  17. Pharm. Management

Student's details:

Course Enrolled Pass-out
M.S (Pharm) 229 203
M.B.A 47 44
Ph.D 53 10
Total 329 257

Academic excellence

In 2021-22, the Institute has published 76 articles in journals of repute (till 31st October, 2021). Institute has filed 198 patents applications (families) and out of which 109 patents are granted/issued till date. Since the inception of academic programme (till 8th November, 2021), 4004 students have passed out (Masters 2968, MBA 689& Ph.D. 347).

Teacher-Student ratio:-

Course Ratio (Student / Faculty)
Year 2020-21 2021-22 Total Ratio (S : F)
Ph. D. 9/26 = 0.35:1 52/25= 2.08:1 1.21:1
Masters' (Science) 216/23 = 9.39:1 229/22 = 10.41 : 1 9.9:1
MBA (Pharm.) 46/3 = 15.33 : 1 47/3 = 15.67 : 1 15.5:1


  1. Neglected diseases-
    Research is carried out in the areas of tuberculosis, leishmaniasis and malaria. New molecules are being synthesized and their mechanisms of action are being worked out.
  2. Other diseases
    Metabolic pathways in diseases like inflammation, infection, cancer, diabetes, neurodegeneration are being worked out.
  3. Drug development and formulation
    1. Improvement of oral bioavailability, synergistic anticancer efficacy and reduced toxicity of drugs has been attempted.
    2. New formulations are being developed.
    3. Green sustainable synthesis of APIs, KSMs and intermediates
    4. Standardization of Herbal drugs and formulations
    5. Toxicological studies
  4. Other Areas
    1. Biopharmaceuticals
    2. Herbal medicines
    3. Epigenetics
    4. Chemo-enzymatic synthesis of drugs
    5. Monograph on herbals is being developed
    6. Study of the effect of RNA aptamers on stabilization of misfolded proteins
    7. Assessment of an appropriate and reliable method to diagnose neuropathic pain
    8. Artificial intelligence, Machine Learning, Big data Analytics
    9. Utility of Physiology Based Pharmacokinetic (PBPK) Modeling in prediction of PK of drugs in special populations and in study of food effects on drug PK
    10. HEOR and pharmacovigilance

Innovation / knowledge transfer

  1. Patents and Commercialisation: 198 (filed)/109 (granted)/07 (licensed) since inception
  2. Total revenue generated FY 2020-21: Rs. 8.57 crore and FY 2021-22: Rs. 4.84 crore (till 28-10-2021)
  3. H Index - NIPER S.AS. Nagar - H index- 120 (till 30-09-2021 Scopus)
  4. H Index and Citation per faculty for NIPER SAS is one of the highest among the premier research institutes of India.

Institution leadership

  1. Ranked 4th in the category 'Pharmacy' in NIRF MHRD 2021 Rankings.
  2. 4th in QS ranking India, globally 151-200, under Pharmacy & Pharmacology subject area in 2021.
  3. Institute has initiated skill development trainings programs for pharmacy and science students for different role in pharmaceutical industry.
  4. One-third of faculty strength of NIPER SAS Nagar has been listed among the top 2% scientists in the world.
  5. Chemical Research Society of India (CRSI) Medal
  6. TWAS fellow in recognition of his achievements in fields of Structural, Cell, Molecular Biology and Drug Discovery.
  7. AAiPS "Distinguished Young Educator and Research Scholarship-2021" Award.
  8. Dissolution Research Presentation India (DRPI)-2021
  9. 6th German Pharm-Tox Summit 2021 award by the German Society

Impact of NIPER

The success of NIPER, S.A.S. Nagar has encouraged the GoI to set up more NIPERs across the country to meet the growing demands of the pharmaceutical sector. In addition, NIPER has carried out training programmes for personnel from India and abroad under ITEC-SCAAP, capacity building programmes (World Bank-sponsored) and SMPIC. There also has been participation of the institute in rebuilding of public sector enterprises like IDPL, BCPL, HAL, etc.

Skill development trainings under skill vigyan program were sanctioned by PSCST & DBT program for different roles in pharmaceutical industry.

2. NIPER- Ahmedabad

NIPER-Ahmedabad was set up in 2007 is currently functioning from a transient, temporary building on a 60-acre landsite at Gandhinagar since August 2016. The institute is presently offering MS and Ph.D. programs in 07 streams and from academic year 2020 NIPER-A has started Masters program in MBA (Pharm.). The interdisciplinary courses and cultural diversity at NIPER Ahmedabad sparks the spirit of innovative research and all-round development of its students. The location of the Institute ensures a symbiotic association with Pharmaceutical Industries, Medical centers, and technological universities. The Institute aspires to serve as a good launching platform to revamp the pharmaceutical education and research and to initiate the new era of Pharmaceutical and biomedical sciences.


NIPER offers Masters' and Ph.D. degrees in 7 streams and caters to the various needs of pharmaceutical industry:

  1. Biotechnology
  2. Medicinal Chemistry
  3. Medical Devices
  4. Natural Products
  5. Pharmaceutical Analysis
  6. Pharmacology and Toxicology
  7. Pharmaceutics

Students details:

Course Enrolled Pass-out
M.S (Pharm) 155 107
Ph.D 31 01
Total 186 108

Teacher-Student ratio:

Presently 1: 18.1 (21 Faculty: 382 students)

Research: Active Research Areas:

  • Department of Biotechnology
  • Department of Medicinal Chemistry
  • Department of Medical Devices
  • Department of Natural Product
  • Department of Pharmaceutical Analysis
  • Department of Pharmacology and Toxicology
  • Department of Pharmaceutics

Impact of NIPER :

NIPER-Ahmedabad is committed to building human resource for promoting research and development in the country and contribute towards "Make in India" initiative as a part of its national responsibility. The Institute has established itself as one of the top technological pharmacy research institutes in the country with research collaboration as an integral part of the growth strategy. It has expanded its outreach to the industry as well as collaborated with the best academic institution of USA, UK, Australia, Ireland and Malaysia for collaborating research, faculty visit, syllabus up-gradation and regulatory reforms with several industries and leading institutes. The Institute has conducted various conferences, symposiums, discussions which were attended by masters' students, PhD, Post Docs and researchers from academia and industry. The discussions are scientifically stimulating and have led to healthy cross talks and collaborations.

3. NIPER Guwahati

NIPER Guwahati started functioning from 2008 under the Mentor Institute, Guwahati Medical College, Guwahati up to July 2017. Dr. USN Murty took over the charge of the Director of the Institute from 3rd November 2016. NIPER-Guwahati is now functioning from its own permanent campus at Changsari, Kamrup (Rural), North Guwahati, Assam from January 2020.


  1. Pharmacology and Toxicology
  2. Biotechnology
  3. Pharmacy Practice
  4. Pharmaceutics
  5. Pharmaceutical Analysis
  6. Pharmaceutical Technology (Formulations)
  7. Medicinal Chemistry
  8. Medical Devices

Students Details

Course Enrolled Pass-out
M.S (Pharm) 125 70
Ph. D. 25 02
Total 150 72

Teacher-Student ratio:

  • Pharmacy Practice : 1:6
  • Pharmacology and Toxicology: 1:10
  • Biotechnology : 1:6
  • Pharmaceutics : 1:12
  • Pharmaceutical Analysis : 1:9
  • Pharmaceutical Technology (Formulations): 1:5
  • Pharmaceutical Analysis : 1:9
  • Pharmaceutical Analysis : 1:9



Development of Biopharmaceuticals using Biomolecular Engineering/Synthetic Biology approaches -

  1. Oncogenic mRNA cleaving Deoxyribozymes
  2. Development of new approaches of Immune rerouting for targeting cancer cells
  3. Riboswitch mediated gene regulation of oncogenes
  4. Generation of random Protein coding sequences & Aptamer based therapeutics and diagnostic tools


  1. Molecular Pharmacology
  2. Development of Cancer targeted drug delivery systems
  3. Screening Indian biodiversity and Indian Systems of Medicine in search of newer compounds in the area of inflammation, arthritis, diabetes, cancer and hepatoprotective activities
  4. Targeting RANKL for the treatment of inflammation and cancer induced bone disorders.
  5. Screening of NCE's & North-East plant products for anti-Parkinson's and antidepressant effects.
  6. Studies on the mitigation of drug induced toxicities through natural products derived from Northeast India.


  1. Study of drug utilization pattern for antiepileptic and antipsychotic drugs
  2. Impact of Lipodystrophy on Quality of Life, Social and Psychological Aspects in PLHIV on First line and Second line Anti Retroviral regimen
  3. Haemovigilance: An important tool for improving safe blood transfusion practices


  1. Dosage form design, development, optimization and evaluations for BCS-II-IV drugs
  2. Micro-and nanotheragnosis concepts for the early detection and treatment of malignant diseases and other life-threatening diseases
  3. Eradication of biofilm-producing microorganisms from the surfaces of implanted or inserted medical devices into human body
  4. Ligand anchored lipid/polymer-mediated nanoarchitectonics
  5. Pharmacoengineered delivery devices to fight against neglected diseases
  6. Pharmaceutical 3D & 4D Printing Technology
  7. Extrusion based biofilaments processing for fused-filaments applications
  8. Translational cutting-edge pharmaceutical research & development


  1. Bioavailability, IVIVC and IVIVE analysis
  2. Analytical (ICH Guidelines) & Bio-analytical (FDA-Industry Guidance) method development &validation using HPLC, UPLC, LC- MS/MS
  3. Short-term/accelerated, mid-term and long-term stability testing of formulations and degra- dation studies.
  4. Pharmacokinetic, Toxicokinetic, Metabolic and Impurity profiling

Impact of NIPER:

The establishment of NIPER-Guwahati has given a strong boost to the promotion of Pharmaceutical Education & Research in the North East region of India. Research efforts of NIPER Guwahati have revived the studies on medicinal value of local herbs of North East Region against various diseases. NIPERGuwahati has organized several virtual/physical conferences, meeting, workshop, skill development programme, etc. to promote & foster entrepreneurship culture in NER. This institute is supporting traditional healers & potential entrepruenrs from different states of NER like Assam, Mizoram, Meghalaya, Sikkim, Tripura, etc to promote them from regional to global level.

The newly joined faculty members of NIPER-Guwahati have been awarded several Extramural funded projects in the year 2020-21 from different funding agencies like ICMR, SERB, DST, BIRAC-NER scheme, etc.

4. NIPER Hajipur

NIPER-Hajipur started functioning in 2007 under the mentorship of Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna till 31.10.2018. Its own first Director assumed charges with effect from 01.11.2018, and the Institution is now under infused with zeal and vigor in achieving center of excellence for higher education, research and development in pharmaceutical sciences, conceived to provide leadership quality in pharmaceutical sciences and other related areas.


  1. M.S and PhD. in Biotechnology,
  2. M.S. and PhD in Pharmacy Practice
  3. M. S. and PhD in Pharmacology & Toxicology
  4. M.S. and PhD in Pharmaceutical Analysis (From 2021-22) and
  5. M.S. and PhD in Pharmaceutics (From 2021-22) with an annual intake in Biotechnology 18, Pharmacy Practice 16, Pharmacology & Toxicology 17, Pharmaceutical Analysis 10 and Pharmaceutics 11 for each course.

Details of faculty & staff are appended below

Academic: Director & 09 (regular)
Non-Academic: 06 (regular), 03 (on contract)

Students detail:

Course Enrolled Pass-out
M.S (Pharm) 73 42
Ph. D. 15 05
Total 88 47

Teacher-Student ratio: 1:10


Departmental Research Activities: Dept. of Biotechnology

  • Application of Nanotechnology as a biosensor for detection and diagnosis of diseases.
  • Creating solutions that utilize micro-and nanoscale technologies for the treatment of neurological diseases.

Departmental Research Activities: Dept. of Pharmacy Practice

  • Medication safety studies such as DUE/DUR, Drug interactions/Pharmacoeconomics studies in clinical facilities
  • Clinical efficacy and safety studies along with pharmacovigilance and materiovigilance activity pertaining to infectious diseases such as HIV, tuberculosis and Cancer. Further to extrapolate the molecular findings

Departmental Research Activities: Dept. of Pharmacology & Toxicology

  • Developing pharmacologic, genetic, and stem cell-based interventions for reversing the mood and cognitive deficits ageing, Alzheimer's disease, and cancer or chemotherapy-induced brain disorders.
  • Identify the simple, cost-effective, and easy-to-use biomarkers for detection, prognosis, and therapeutic assessment of neurological disorders, cancer, diabetes, and infectious diseases.

Impact and achievements

The Institute has successfully produced 424 PG and 16 PhD students in three disciplines who are either employed in different pharmaceutical industries or pursuing their higher education in different institutes or universities across the globe. Many of NIPER Hajipur ex-students are engaged as faculty at different institutions. Pharmacology and Toxicology laboratory was established in October 2020. During the year, the animal house has received CPCSEA approval.

5. NIPER Hyderabad

NIPER-Hyderabad started functioning in September 2007 in the premises of IDPL, R&D centre, Balanagar, Hyderabad. The Institution's vision is to serve as a leading global institution in higher learning and research in Pharmaceutical Sciences and Management. Its mission is to be one of the principal sources of professional manpower in the field and strengthen the Indian Pharmaceutical industry through conducting Post Graduate and PhD courses. The institute is well equipped with the state-of-the-art facilities for carrying out advanced research in the areas of pharmaceutical importance.


  1. Medicinal Chemistry
  2. Pharmaceutical Analysis
  3. Pharmacology & Toxicology
  4. Pharmaceutics
  5. Process Chemistry
  6. Regulatory Toxicology
  7. Natural Products
  8. Pharmacoinformatics
  9. Regulatory Affairs
  10. Medical Devices and Pharmaceutical Management

Details of Faculty & Staff:

  1. Regular Faculty:20
  2. Regular Staff :12
  3. Contractual Faculty:06
  4. Contractual Administrative and Technical Staff ::02

Students details:

Course Enrolled Pass-out
M.S (Pharm) 187 145
Ph. D. 45 25
Total 232 170

Teacher-Student ratio

Presently 1:12

Core Research areas:

  • Integrated Drug Discovery & Product Development Programmes
  • Cancer, Inflammation and related proliferative diseases
  • Diabetes and other metabolic disorders
  • Neurodegenerative diseases
  • Infectious diseases
  • Psoriasis
  • In vitro and in vivo screening
  • Development of novel Process for NCEs, Bulk Drugs and Intermediates
  • Development of Analytical Methods, Impurity Profiling and Stability studies
  • Solid state characterization
  • Targeted drug delivery systems

Innovation / knowledge transfer

  1. Patents and commercialization- 12 patents filed in areas of Cancer Drug Discovery, Formulation Development and Analytical Method Development
  2. Internal Revenue Generation: 10.52 Crores (FY 2020-21)

Impact of NIPER:

Creation of human resources by imparting high quality education and training in pharmaceutical sciences helped the pharmaceutical industry. Serve as a research institute and focusing on thrust areas of national and international relevance. Institute helped in fostering academic and industrial collaborations to address some of the key issues in the pharma sector and the needs of Pharmaceutical industry in the country.

6. NIPER Kolkata

National Institute of Pharmaceutical Education & Research Kolkata (NIPER-Kolkata) was established in the year 2007 and is presently functioning at 'Chunilal Bhawan', Maniktala, Kolkata to promote Excellence in the field of Pharmaceutical Education and Research and contribute to the growth of the Pharmaceutical Industry in India through teaching, research and scholarship. At the moment teaching and research remains central function and overriding goal


  1. Medicinal Chemistry
  2. Natural Products
  3. Phamacoinformatics
  4. Pharmacology & Toxicology
  5. Rare disease
  6. Pharmaceutics
  7. Medical Devices

Sanctioned strength of staff, in position and vacancy position:

NIPER Kolkata has 12 Teaching and 13 Non-Teaching regular employees. Two teaching faculties are in contractual positions. In addition to the above, 19 are in outsourced/contractual non-teaching employees for the office.

Students details:

Course Enrolled Pass-out
M.S (Pharm) 82 31
Ph. D. 13 02
Total 95 33

Teacher-Student ratio: 1:11


  • Novel drug delivery system and 3D bioprinting
  • Biomaterial optimization for Medical Devices
  • Biosensor development
  • Advanced manufacturing of dosage forms
  • Nucleosides as therapeutics agents
  • Development of sphingosine inhibitors
  • Green Chemistry & Flow Chemistry for API synthesis
  • Targeting biofilms and quorum sensing.
  • Development of DNA based therapeutics and diagnostic tools
  • Structural bioinformatics: new drug discovery/repurposing for Infectious Diseases and Metabolic disorders.
  • Computational designing of anti-microbial agents
  • Metabolic bio-engineering for production of small molecules
  • Transcriptomics and Proteomic profiling of phytopharmaceuticals and Herbal formulations
  • Diabetes mediated Non-alcoholic steatohepatitis and Hepatocellular carcinoma: Pharmacological and biochemical characterization.
  • Diabetes associated neurological complications
  • Genome editing in immune biotechnology
  • Phytochemistry; chemicals transformation: Herbal products analysis
  • Network Pharmacology of herbal medicines in respiratory diseases

Establishing Drug Testing Lab (DTL) facility for surgical dressings and drug eluting implants under process.

Impact of NIPER:

  1. A total of 508 highly skilled students have graduated.
  2. 4 scholars have been awarded with the Ph.D. degree.
  3. 339 students are engaged to work in companies/institutions.
  4. 235 high quality research papers have been published.
  5. In vivo animal imaging, confocal microscopy, 3D printing and flow reactor, BSL-2 facility has been established to promote research activities at NIPER Kolkata.
  6. Currently the institute is funded by research projects in the tune of Rs.3.9 crore from various national funding agencies.
  7. NIPER-Kolkata has developed product/provided scientific data for BIOWIN products of M/s. Bio Green Remedies Pvt. Ltd. Hyderabad by computational machine.
  8. Scientist Chair in the name of Acharya Prafulla Chandra Roy funded by M/S Bio Green Remedies Pvt. Ltd is has been created by NIPER Kolkata
  9. NIPER-Kolkata has introduced a yearly award in the name of Shri. Acharya Prafulla Chandra Ray Flow Chemistry Technology Award" with a citation and cash award of Rupees One Lakh for outstanding contribution in the concept of flow reaction application in API.
  10. Evaluation of chlorine dioxide Gaseous Disinfection product by M/s. Inventz Life Science Pvt. Ltd. Chennai and its currently marketed in the trade name of ORNISTOP has been conducted by NIPER Kolkata.
  11. Number of patents: One


National Institute of Pharmaceutical Education and Research (NIPER), Raebareli was established in 2008. It is currently running from its transit campus in Lucknow with a world class central Instrumentation facility within its premises and an animal house to perform pre-clinical studies.


  1. Medicinal Chemistry
  2. Pharmaceutics
  3. Pharmacology and Toxicology
  4. Regulatory Toxicology
  5. Biotechnology

Academic/Non-Academic staff:-

Administrative Staff : 05
Academic Staff
Associate Professors 05
Assistant Professors 11
Research Associate 01
Staff: Technical 03
Multi-Task Staff 13

Second Phase recruitment for regular staff is under process and the posts are likely to be filled shortly

Student details:

Course Enrolled Pass-out
M.S (Pharm) 90 60
Ph. D. 19 03
Total 109 63

Teacher: Student Ratio - 1:13


  1. Active Research Areas:
    • Neurodegenerative diseases
    • Heavy Metal Toxicity
    • Japanese Encephalitis
    • Tuberculosis
    • Development and evaluation of drugs using Nano formulations.
  2. Development of green and eco-friendly synthetic methods
  3. Projects: Ongoing: 09 worth Rs. 2.40 Cr.

Impact of NIPER:

NIPER-Raebareli has emerged as an Institution of significance both in academics and research particularly in Central India with modern laboratories, highly sophisticated instrument. We have achieved number of milestones and Pharma industries have shown interest in collaborating with us be- sides training our students for short term and long term basis.

The Institute initiated collaborative projects/ work with national and international academic and research institutes in the area of immediate importance like such as Japanese Encephalitis, Tuberculosis and Neurodegenerative diseases. An online portal has been created to facilitate seamless sample analysis for drug discovery. We are also providing highly skilled human resources for the Indian Pharmaceutical Industry.

National Institute of Pharmaceuticals Education and Research (NIPERs) Contact List Directors of NIPER Landline Number Email Address
1 Prof. Dulal Panda NIPER-Mohali 0172-2214690 0172-2214697 director[at]niper[dot]ac[dot]in SAS Nagar, NIPER Mohali, Punjab - 160062
2 NIPER-Ahmedabad 079-66745555
Palaj Opp. Air Force Station Head Quarter, Gandhinagar-382355, Gujarat.
3 Dr. Shashi Bala Singh NIPER-Hyderabad 040-23073741 director[dot]niperhyd[at]gov[dot]in
NIPER, Hyderabad IDPL Township, Balangar, Hyderabad-500007
4 Dr.V. Ravichandiran, NIPER-Hajipur (Additional Charge) 0612-2631565 directorniperkolkata[at]gmail[dot]com
E.P.I.P. Campus, Industrial Area, Hajipur-844102, Bihar
5 Dr.V. Ravichandiran, NIPER-Kolkata 033-24995803
Chunilal Bhawan, 168, Maniktala main road, Kolkata-700054, West Bangal
6 Dr. USN Murty NIPER-Guwahati 0361-2132751 murtyusn[at]gmail[dot]com
Sila Katamur (Halugurisuk) P.O.: Changsari, Dist: Kamrup, Assam, Pin: 781101, Assam, India
7 Dr. USN Murty NIPER-Raebareli (additional charge) 0535-2700851 director[at]niperraebareli[dot]edu[dot]in Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow (UP) - 226002
Min Description: 
Nurturing Quality & Excellence in Pharma Education and Research